The current study was a meta-analysis of 18 large, prospective, randomized, controlled studies with a total of 4146 patients. The included studies had "cardiovascular," "mortality," or "blood pressure ...

Add Yahoo as a preferred source to see more of our stories on Google. Inspire Sleep Apnea Innovation Around 22 million Americans have sleep apnea. Traditional continuous positive airway pressure, or ...

The obesity and diabetes medication tirzepatide (Mounjaro, Zepbound) reduced obstructive sleep apnea events by as much as two-thirds in new clinical trials. The abstract (but not the complete study) ...

People with obesity who received the weight-loss drug Zepbound had fewer obstructive sleep apnea events, or episodes of stopped breathing during sleep. The research by drug maker Eli Lilly included ...

DANVILLE, Va. (WSET) — Sovah Health is now offering a new kind of sleep apnea treatment for those who cannot useContinuous Positive Airway Pressure (CPAP) therapy. Obstructive sleep apnea impacts 22 ...

Breakthrough sleep apnea medication AD109 shows promising results in phase 3 trials, potentially helping 30 million Americans with the condition.

As nights get hotter around the globe due to climate change, the prevalence of sleep apnea is expected to increase by as much ...

A late-stage trial of Eli Lilly’s weight loss drug Zepbound showed promising results in treating sleep apnea symptoms in obese adults, the company announced Wednesday, the latest findings suggesting ...